Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Johannes C. Fischer, MD, Sascha Raschke, Guido Kobbe, PhD, Roland Fenk, MD, Michael Rosskopf, Sabrina Pechtel, Ulrich-Peter Rohr, PhD, Arndt von Haeseler, PhD, Peter Wernet, PhD, Daniel Tenen, PhD, Rainer Haas, PhD, Ralf Kronenwett, PhD

Blood (2006) 108 (11): 3382.

https://doi.org/10.1182/blood.V108.11.3382.3382

Published: 2006

Journal Articles

Escalation Treatment Algorithm with Bortezomib, Dexamethasone and Bendamustine for Patients with Relapsed or Refractory Multiple Myeloma: A Singel Centre Experience.

Roland Fenk, MD, Mark Michael, Fabian Zohren, Thorsten Graef, MD, Arkosch Czibere, MD, Sebastian Balleisen, MD, Frank Neumann, MD, Ulrich-Peter Rohr, MD, Ulrich Steidl, MD, Rainer Haas, MD, Guido Kobbe, MD

Blood (2006) 108 (11): 3540.

https://doi.org/10.1182/blood.V108.11.3540.3540

Published: 2006

Journal Articles

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Roland Fenk, MD, Mark Korthals, Guido Kobbe, MD, Ulrich Steidl, MD, Thorsten Graef, MD, Ulrich-Peter Rohr, MD, Leilani Ruf, MD, Barbara Hoyer, MD, Frank Neumann, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2004) 104 (11): 4871.

https://doi.org/10.1182/blood.V104.11.4871.4871

Published: 2004

Journal Articles

Primary human CD34 + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Ulrich Steidl, Simone Bork, Sebastian Schaub, Oliver Selbach, Janette Seres, Manuel Aivado, Thomas Schroeder, Ulrich-Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Stefan R. Bornstein, Helmut L. Haas, Guido Kobbe, Daniel G. Tenen, Rainer Haas, Ralf Kronenwett

Blood (2004) 104 (1): 81–88.

https://doi.org/10.1182/blood-2004-01-0373

Published: 2004

Journal Articles

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34 + hematopoietic stem cells

Ulrich Steidl, Ralf Kronenwett, Ulrich-Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Manuel Aivado, Judith Koch, Olga Modlich, Hans Bojar, Norbert Gattermann, Rainer Haas

Blood (2002) 99 (6): 2037–2044.

https://doi.org/10.1182/blood.V99.6.2037

Published: 2002

NARROW

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Escalation Treatment Algorithm with Bortezomib, Dexamethasone and Bendamustine for Patients with Relapsed or Refractory Multiple Myeloma: A Singel Centre Experience.

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Primary human CD34 + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34 + hematopoietic stem cells

Email alerts

ASH Publications

American Society of Hematology

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Escalation Treatment Algorithm with Bortezomib, Dexamethasone and Bendamustine for Patients with Relapsed or Refractory Multiple Myeloma: A Singel Centre Experience.

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Primary human CD34 + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34 + hematopoietic stem cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only